Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA.
Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
J Cardiothorac Vasc Anesth. 2022 Jan;36(1):118-124. doi: 10.1053/j.jvca.2021.05.002. Epub 2021 May 12.
The objective of this study was to identify novel serum biomarkers specific to postoperative delirium after major cardiac surgery to provide insight into the pathologic processes involved in delirium and its sequelae.
Nested, case-control study.
Cardiac surgical intensive care unit in a single-site hospital setting.
The study comprised 24 older adults (aged >60 years) undergoing major cardiac surgery with cardiopulmonary bypass.
None.
The primary outcome was a positive screen for delirium from postoperative days one through three based on criteria included in the long form of the Confusion Assessment Method. A multiplexed proteomic approach was applied using proximity extension assays to identify and quantify proteins found in serum collected on the day of surgery and postoperative day one in delirious and nondelirious patient cohorts. An increase in serum fibroblast growth factor (FGF)-21 levels was identified in the delirious cohort from a presurgery baseline of (mean ± standard deviation) 5.0 ± 1.1 log2 abundance (95% confidence interval [CI], 4.3-5.7) to 6.7 ± 1.6 log2 abundance (95% CI, 5.7-7.7; p = 0.01) postsurgery. A similar increase was identified in FGF-23 from a presurgery baseline of 1.7 ± 1.3 log2 abundance (95% CI, 0.8-2.5) to 3.4 ± 2.2 log2 abundance (95% CI, 2.0-4.8; p = 0.06) postsurgery. An increase in interleukin-6 serum levels also was identified in the delirious cohort from a presurgery baseline of 3.8 ± 1.1 log2 abundance (95% CI, 3.1-4.5) to 8.7 ± 1.9 log2 abundance (95% CI, 7.5-9.9; p < 0.0001) postsurgery. However, the increase in interleukin-6 serum levels of the nondelirious cohort also met the study's threshold for statistical significance (p < 0.0001). Finally, an increase in monocyte chemotactic protein-3 serum levels was identified in the delirious cohort from a presurgery baseline of 4.1 ± 0.9 log2 abundance (95% CI, 3.6-4.7) to 6.1 ± 2.0 log2 abundance (95% CI, 4.8-7; p = 0.009) postsurgery.
FGF-21, FGF-23, interleukin-6, and monocyte chemotactic protein-3 serum levels were increased postoperatively in patients who developed delirium after major cardiac surgery. This study identified two members of the FGF family as potential putative systemic biomarkers for postoperative delirium after cardiac surgery, suggesting a possible role for metabolic recovery in the pathophysiologic mechanisms underlying neurocognitive dysfunction.
本研究旨在确定特定于心脏大手术后谵妄的新型血清生物标志物,以深入了解谵妄及其后遗症涉及的病理过程。
巢式病例对照研究。
单站点医院的心脏外科重症监护病房。
研究包括 24 名年龄超过 60 岁的接受体外循环心脏大手术的老年人。
无。
主要结局是根据包括在长形式混乱评估方法中的标准,在术后第 1 天至第 3 天对谵妄进行阳性筛查。在手术当天和术后第 1 天采集的血清中,应用邻近延伸测定法对来自术后第 1 天的清醒和非清醒患者队列的蛋白质进行鉴定和定量。在手术后,清醒组的血清成纤维细胞生长因子(FGF)-21 水平从术前基线的(平均值±标准差)5.0±1.1 log2 丰度(95%置信区间[CI],4.3-5.7)增加到 6.7±1.6 log2 丰度(95%CI,5.7-7.7;p=0.01)。在手术后,也在 FGF-23 中观察到类似的增加,从术前基线的 1.7±1.3 log2 丰度(95%CI,0.8-2.5)增加到 3.4±2.2 log2 丰度(95%CI,2.0-4.8;p=0.06)。在清醒组中,白细胞介素-6 血清水平也从术前基线的 3.8±1.1 log2 丰度(95%CI,3.1-4.5)增加到术后 8.7±1.9 log2 丰度(95%CI,7.5-9.9;p<0.0001)。然而,非谵妄组白细胞介素-6 血清水平的增加也达到了研究的统计学意义阈值(p<0.0001)。最后,在清醒组中,单核细胞趋化蛋白-3 血清水平从术前基线的 4.1±0.9 log2 丰度(95%CI,3.6-4.7)增加到术后 6.1±2.0 log2 丰度(95%CI,4.8-7;p=0.009)。
在接受心脏大手术后发生谵妄的患者中,FGF-21、FGF-23、白细胞介素-6 和单核细胞趋化蛋白-3 血清水平在术后升高。本研究确定了成纤维细胞生长因子家族的两个成员作为心脏手术后谵妄的潜在系统生物标志物,这表明代谢恢复可能在神经认知功能障碍的病理生理机制中起作用。